2-PYRIMIDINECARBOXYLIC ACID, 5-METHOXY-, 95.0%, 10g

5-(2-Bromobenzoyl)-2-chloropyridine, 97.0%, 1g

4-(N,N-Diphenylamino)benzaldehyde, 95.0%, 1g

GC capillary column ROTI®Cap-5, 10 m, 0.32 mm, 0.10 µm, 1 Piece(s)

h-lle-otbu.hcl, 98.0%, 25g

2-Bromo-6-methoxypyrazine, 95.0%, 500mg

Bruceine D, 99.53%, 250mg

Sodium; [1,2,3]thiadiazole-5-thiolate, 95.0%, 1g

tert-Butyl 5'-oxo-8-azaspiro[bicyclo[3.2.1]octane-3,3'-pyrrolidine]-8-carboxylate, 95.0%, 250mg

5-(chloromethyl)dihydro-2(3H)-furanone, 95.0%, 1g

1-(6-Methylpyrimidin-4-yl)ethanone, 95.0%, 5g

1-(4-Chloro-2-hydroxyphenyl)ethanone, 97.0%, 1g

Dihydro-1H-cyclopenta[1,2-c:3,4-c']difuran-1,3,4,6(3aH,3bH,6aH)-tetraone, 95.0%, 250mg